Lin-Lin Bu, the Annals of Surgical Oncology Social Media Committee. ASO Author Reflections: Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Squamous Cell Carcinoma—A Pathway to Improved Clinical Outcomes. // Annals of Surgical Oncology. – 2025. – DOI: 10.1245/s10434-025-17308-7. – URL: https://doi.org/10.1245/s10434-025-17308-7
Lin-Lin Bu & the Annals of Surgical Oncology Social Media Committee (2025). ASO Author Reflections: Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Squamous Cell Carcinoma—A Pathway to Improved Clinical Outcomes. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-025-17308-7
Lin-Lin Bu and the Annals of Surgical Oncology Social Media Committee. “ASO Author Reflections: Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Squamous Cell Carcinoma—A Pathway to Improved Clinical Outcomes.” Annals of Surgical Oncology, 2025. doi:10.1245/s10434-025-17308-7.
@article{Bu2025,
title = {ASO Author Reflections: Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Squamous Cell Carcinoma—A Pathway to Improved Clinical Outcomes},
author = {Bu, Lin-Lin and Committee, the Annals of Surgical Oncology Social Media},
journal = {Annals of Surgical Oncology},
year = {2025},
doi = {10.1245/s10434-025-17308-7},
url = {https://doi.org/10.1245/s10434-025-17308-7}
}